Abstract Microvillus inclusion disease (MVID) is an autosomal recessive disorder caused by biallelic mutations in the MYO5B or STX3 gene. Refractory diarrhea and malabsorption are the main clinical manifestations. The aim of this study was to investigate the clinical features and MYO5B gene mutations of an infant with MVID. A 21-day-old female infant was referred to the hospital with the complaint of diarrhea for 20 days. On physical examination, growth retardation of the body weight and length was found along with moderately jaundiced skin and sclera. Breath sounds were clear in the two lungs and the heart sounds were normal. The abdomen was distended and the veins in the abdominal wall were observed. The liver and spleen were not palpable. Biochemical analysis revealed raised serum total bile acids, bilirubin, transaminases and γ-glutamyl transpeptidase while decreased levels of serum sodium, chloride, phosphate and magnesium. Blood gas analysis indicated metabolic acidosis. The preliminary diagnosis was congenital diarrhea, and thus parenteral nutrition was given along with other symptomatic and supportive measures. However, diarrhea, metabolic acidosis and electrolyte disturbance were intractable, and the cholestatic indices, including transaminases, γ-glutamyl transpeptidase, bilirubin and total bile acids, remained at increased levels. One month later, the patient was discharged and then lost contact. On genetic analysis, the infant was proved to be a compound heterozygote of the c.310+2Tdup and c.1966C > T(p.R656C) variants of the gene MYO5B, with c.310+2Tdup being a novel splice-site mutation. MVID was thus definitely diagnosed.
CHENG Ying,LIANG Hong,CAI Na-Li et al. Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease[J]. CJCP, 2017, 19(9): 968-974.
CHENG Ying,LIANG Hong,CAI Na-Li et al. Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease[J]. CJCP, 2017, 19(9): 968-974.
Cutz E, Rhoads JM, Drumm B, et al. Microvillus inclusion disease:an inherited defect of brush-border assembly and differentiation[J]. N Engl J Med, 1989, 320(10):646-651.
Davidson GP, Cutz E, Hamilton JR, et al. Familial enteropathy:a syndrome of protracted diarrhea from birth, failure to thrive, and hypoplastic villus atrophy[J]. Gastroenterology, 1978, 75(5):783-790.
[4]
van der Velde KJ, Dhekne HS, Swertz MA, et al. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations[J]. Hum Mutat, 2013, 34(12):1597-1605.
[5]
Phillips AD, Schmitz J. Familial microvillous atrophy:a clinicopathological survey of 23 cases[J]. J Pediatr Gastroenterol Nutr, 1992, 14(4):380-396.
[6]
Michaux G, Massey-Harroche D, Nicolle O, et al. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease[J]. Biol Cell, 2016, 108(1):19-28.
[7]
Qiu YL, Gong JY, Feng JY, et al. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis[J]. Hepatology, 2017, 65(5):1655-1669.
[8]
Chen Y, Tian L, Zhang F, et al. Myosin Vb gene is associated with schizophrenia in Chinese Han population[J]. Psychiatry Res, 2013, 207(1-2):13-18.
Xue Y, Ankala A, Wilcox WR, et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing:single-gene, gene panel, or exome/genome sequencing[J]. Genet Med, 2015, 17(6):444-451.
[11]
Sun Y, Ruivenkamp CA, Hoffer MJ, et al. Next-generation diagnostics:gene panel, exome, or whole genome?[J]. Hum Mutat, 2015, 36(6):648-655.
[12]
Müller T, Hess MW, Schiefermeier N, et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity[J]. Nat Genet, 2008, 40(10):1163-1165.
[13]
Engevik AC, Goldenring JR. Trafficking ion transporters to the apical membrane of polarized intestinal enterocytes[J]. Cold Spring Harb Perspect Biol, 2017.[Epub ahead of print]
[14]
Girard M, Lacaille F, Verkarre V, et al. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease[J]. Hepatology, 2014, 60(1):301-310.
[15]
Siahanidou T, Koutsounaki E, Skiathitou AV, et al. Extraintestinal manifestations in an infant with microvillus inclusion disease:complications or features of the disease?[J]. Eur J Pediatr, 2013, 172(9):1271-1275.
[16]
Gonzales E, Taylor SA, Davit-Spraul A, et al. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease[J]. Hepatology, 2017, 65(1):164-173.
[17]
Vogel GF, Janecke AR, Krainer IM, et al. Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease[J]. Traffic, 2017, 18(7):453-464.
[18]
Erickson RP, Larson-Thomé K, Valenzuela RK, et al. Navajo microvillous inclusion disease is due to a mutation in MYO5B[J]. Am J Med Genet A, 2008, 146A(24):3117-3119.
[19]
Szperl AM, Golachowska MR, Bruinenberg M, et al. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease[J]. J Pediatr Gastroenterol Nutr, 2011, 52(3):307-313.
[20]
Ruemmele FM, Müller T, Schiefermeier N, et al. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease:15 novel mutations and a CaCo-2 RNAi cell model[J]. Hum Mutat, 2010, 31(5):544-551.
[21]
Kelly DA. Preventing parenteral nutrition liver disease[J]. Early Hum Dev, 2010, 86(11):683-687.
[22]
Ruemmele FM, Jan D, Lacaille F, et al. New perspectives for children with microvillous inclusion disease:early small bowel transplantation[J]. Transplantation, 2004, 77(7):1024-1028.
[23]
van Hoeve K, Hoffman I, Fusaro F, et al. Microvillus inclusion disease:a subtotal enterectomy as a bridge to transplantation[J]. Acta Chir Belg, 2016, 116(6):333-339.
